MedMen Begins Construction of Cannabis Cultivation and Manufacturing Facility in California | CashCropToday
0 Shares 1770 Views

MedMen Begins Construction of Cannabis Cultivation and Manufacturing Facility in California

May 24, 2018
1770 Views

Med Men Enterprises has begun construction on a large scale cultivation and manufacturing facility in Desert Hot Springs, California. The new facility is expected to become operational in 2019 and will help the company meet a growing demand for cannabis based products for California recently legalized recreational market. California’s recreational industry is expected to grow to $7.6B in annual sales by 2021.

The new facility will contain a 26,000 sq. ft. Dutch-style greenhouses with a 100% automated and temperature controlled environment. It will also feature two extraction rooms totaling in 19,000 sq. ft. and will be capable of producing 10,000 pounds of cannabis a year.

MedMen has used the same factory layout for its recently developed facility in Mustand, Nevada and will again use the same layout for its upcoming facility in Utica, New York.

MedMen’s cannabis factories include:

  • A state-of-the-art greenhouse manufactured in Holland
  • A tissue culture lab to genetically clean and multiply plants through micro-propagation
  • A flowering room with a 25,000-plant capacity
  • Bakery and Chocolate kitchen rooms
  • Butane and CO2 extraction rooms
  • High-tech analytics lab

You may be interested

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon
Market Watch
278 views
Market Watch
278 views

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon

Editor - November 27, 2018

Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition
Global
196 views
Global
196 views

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition

Editor - November 26, 2018

Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
Manufacturing
193 views
Manufacturing
193 views

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials

Editor - November 26, 2018

GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: